Ron Finklestien

The Surprises of Wall Street: An Intriguing Start to 2024 The Surprises of Wall Street: An Intriguing Start to 2024

“Assume life will be really tough, and then ask if you can handle it. If the answer is yes, you’ve won.” - Charlie Munger Investors have flipped the calendar to a new year, hoping for a fresh...

Analyst Bullish On Phathom Pharmaceuticals Expert Analyst Sees Bright...

Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc.PHAT, raising the price target to $26 from $23. ...

Unearthing Freeport-McMoRan’s Potential in the Copper Market

Exploring Freeport-McMoRan's Indelible Infrastructure Freeport-McMoRan (NYSE:FCX), a...

Exciting Developments Propel Dermata Therapeutics ...

Dermata Therapeutics Inc DRMA stock was trading higher Friday after the company shared some exciting news. The firm announced...

The Plunge of Medical Properties Trust Stock: An Investing Quagmire or Opportunity?

Unfolding Saga of Medical Properties Trust I started scrutinizing...

Bearish Report Predicts Chegg’s Demise Bearish Report Predicts Chegg’s Demise

Chegg, Inc. CHGG shares have plummeted nearly 60% over the past year, and a ...